To kill macrophages, the lethal factor component of Bacillus anthracis toxin binds to a carrier protein (PA), which then interacts with the CMG2 receptor protein on the cell surface and is endocytosed into the cytoplasm. CMG2, as well as TEM8, a second PA receptor not present on macrophages, contain a von Willebrand A domain that is crucial for toxin binding. Here we report that integrin β1, another cell surface von Willebrand A domain protein, can mediate and potentiate anthrax toxin endocytosis. By using microarray-based analysis to globally correlate gene expression profiles with toxin sensitivity, we associated toxin effects with the integrinactivating proteins osteopontin and CD44. Further study showed that PA binds to α4β1-and α5β1-integrin complexes, leading to their conjoint endocytosis, and also interacts-weakly relative to CMG2 but comparably to TEM8-with purified α5β1 complex in vitro. Monoclonal antibody directed against β1-integrin or its α integrin partners reduced PA/integrin endocytosis and anthrax toxin lethality, and hyaluronic acid-which interferes with CD44-mediated integrin activation-had similar effects. Remarkably, whereas deficiency of CMG2 protected macrophages from rapid killing by large toxin doses (>50 ng/mL), by 24 h the toxin-treated cells were dead. Such late killing of CMG2-deficient cells by high dose toxin as well as the late death observed during exposure of CMG2-producing macrophages to low-dose toxin (<1 ng/mL), was dependent on integrin function. Effects of inactivating both CMG2 and integrin were synergistic. Collectively, our findings argue strongly that β1-integrin can both potentiate CMG2-mediated endocytosis and serve independently as a low-affinity PA receptor.
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CD44 | microarray | osteopontin | CMG2 | lethal factor L ethal factor (LF), the principal virulence factor of Bacillus anthracis, inhibits the host MAPK signaling pathway (1) . To enter cells, LF interacts with another B. anthracis protein, protective antigen (PA), which in turn binds to cell surface receptors encoded by two genes: TEM8 (2) and CMG2 (3) . Entry of the PA-LF complex is modulated by the GTPase-activating protein, ARAP3 (4) and LDL-related protein 6 (LRP6) (5) , as well as by other genes that affect autophagy (6) or clathrin-mediated endocytosis (7, 8) . Whereas the mechanisms underlying the effects of ARAP3 on anthrax toxin entry are not known, LRP6 has been shown to interact with TEM8 and CMG2 at the cell surface (5) and to accelerate their endocytosis (9) .
Both TEM8 and CMG2 are type I membrane proteins containing a von Willebrand factor A (vWA) domain (2, 3, 10) , which was identified originally in a serum protein important for the adhesion of blood platelets (11) . Although the normal physiological roles of TEM8 and CMG2 are unknown, both receptor proteins bind to at least some of their ligands, including B. anthracis PA, by interacting through its cation-dependent metal ion-dependent adhesion site (MIDAS) within the vWA domain (10, 12) . Recent evidence indicates that genetic inactivation of CMG2 in mice has profound effects on anthrax toxin lethality, whereas TEM8 inactivation has little effect (13) . The CMG2 and TEM8 receptors are differentially expressed by different types of cells (2, 3, 10).
The vWA domain is also known as an "integrin-like domain" because of its occurrence in multiple, but not all, integrins, and the binding of TEM8 and CMG2 to anthrax toxin has been compared with attachment of integrin to ligands (10, 12) . Integrins are a family of cell surface adhesion proteins that mediate interactions among cells or between cells and the extracellular matrix (14) . Functional integrin complexes are formed by the joining of α and β subunits in the endoplasmic reticulum to form heterodimers, which are then activated by a conformational change that exposes sites involved in ligand binding (14) . Different cells express different integrin complexes, which carry out disparate biological functions (14) . The ligand binding sites of integrin complexes can be blocked highly specifically by monoclonal antibodies (15) (16) (17) (18) (19) .
Previous investigations from our laboratory have used phenotypebased assays to identify host cell proteins that affect the internalization of PA (4, 5) . By using a microarray-based bioinformatics approach, we identified integrin-related genes whose expression correlates with sensitivity to LF-PA in multiple cell lines. This approach has led to discovery of the role of the αβ integrin complex in anthrax toxin endocytosis.
Results
Identification of Genes that Are Differentially Expressed in LF-PASensitive Versus LF-PA-Resistant Cell Lines. Diverse cell lines treated with LF-PA show a wide range of sensitivities to the toxin (9, (20) (21) (22) (23) (24) (25) , and cell death occurs only in cells that have impaired MAPK kinase function (21) . We hypothesized that such phenotypic differences might enable microarray-based identification of other genes whose differentially elevated or reduced expression correlates with differential toxin lethality. Using pattern-search algorithms of GABRIEL (Genetic Analysis By Rules Incorporating Expert Logic), a rule-based system of computer programs designed for genetic analyses (26) , to detect such correlations in a previously published dataset of gene expression profiles for NCI 60 tumor cell lines (27) , we identified nine genes whose reduced expression in LF-PA-resistant versus LF-PA-sensitive cell lines exceeded the variation in global gene expression in those cell lines by at least twofold (Fig. S1 ). The false-positive rate for this threshold choice was 0.09. Using the same search parameters, no genes were found by GABRIEL to be up-regulated in LF-PAresistant and down-regulated in LF-PA-sensitive NCI 60 cell lines.
Quantitative RT-PCR analysis of mRNA from two additional cell lines found previously to be highly sensitive [RAW264.7 mouse macrophages (28)] or highly resistant [M2182 human prostate cancer cells (4, 5) ] to LF-PA showed that expression of three of the nine GABRIEL-detected genes, osteopontin (OPN), DAB2, and cystatin B, in RAW264.7 cells exceeded expression in M2182 cells by 350,000-, 240-, and 80-fold, respectively, consistent with possible association of gene expression with anthrax toxicity; statistically significant differential expression of the other six genes was not observed. OPN is a secreted phosphoprotein known to activate three distinct integrin complexes-α4β1, α5β1, and αvβ3-through its interaction with the cell surface protein CD44 (29) (30) (31) (32) (33) (34) . Importantly, the β components of these integrin complexes contain the vWA domain, which has been shown to be a site for PA binding in the two previously identified anthrax toxin receptors. Together, these considerations raised the possibility that integrins β1 and/or β3, like TEM8 and CMG2, may function as receptors for PA. The following results were obtained in experiments designed to test this notion.
α4β1 and α5β1-integrin Complexes Colocalize with PA at the Macrophage Cell Surface and During Endocytosis. Fluorescence microscopy of RAW264.7 macrophages exposed to PA and anti-β1-integrin antibodies that have been labeled differentially with fluorescent dyes showed colocalization of PA with integrin at the surface of cells maintained at 4°C but no detectable integrin or PA in the cytoplasm (Fig. 1A) . Shift of the cells to 37°C, which leads to PA uptake (4, 5) , resulted in the conjoint internalization of β1-integrin and PA and their continued colocalization in the cytoplasm. However, in the absence of PA, β1-integrin remained at the surface after shift of macrophages to 37°C, indicating that its uptake was dependent on PA. This finding, together with earlier evidence that integrins routinely undergo endocytosis upon binding to specific ligands (35) , argues that PA and β1-integrin are constituents of a PA internalization complex. Supporting this conclusion, fluorescence microscopy using differentially labeled PA and antibodies to integrin α4 or α5, which are binding partners of β1-integrin, showed that these α integrins also colocalized with PA at the cell surface, and upon uptake of PA at 37°C, also in the cytoplasm ( Fig. 1 B and C). Macrophages treated with antibodies to integrin β3 showed no corresponding fluorescence, consistent with earlier investigations showing that this integrin is not expressed in RAW264.7 macrophages (36, 37) .
Unexpectedly, given the concurrent presence on the surface of RAW264.7 cells of CMG2 (38, 39) , which has been described as the major PA receptor (13) , prior treatment of cells with a monoclonal anti-β1 antibody known to highly specifically block the interaction of this integrin with its ligands (18) decreased the binding of PA to RAW264.7 cells by at least 60% as indicated by Western blotting, and also reduced the uptake of PA into the cytoplasm. In contrast, antibody against β3 integrin, which is not produced by these macrophages, did not detectably affect either the attachment ( Fig. 2 A and B) or internalization ( Fig. 2 A and C) of PA. These results suggest that, in RAW264.7 cells, integrin β1 affects the actions of CMG2 as a PA receptor.
Biochemical Evidence of Interaction of α5β1 Complex with PA. Biochemical evidence of the ability of the purified β1-integrincontaining complex α5β1 to bind to PA in vitro, and the dissociation constant for the interaction, were obtained using a surface plasmon resonance (SPR)-based optical biosensor (ProteOn XPR36; Bio-Rad). The equilibrium dissociation constant (K d ) we determined for the PA/integrin complex, 1 μM, approximates that observed for the PA/TEM8 interaction using SPR methods (10), but both values are much lower than the K d calculated from data obtained using a cell-based assay of the effects of PA inhibitors on toxin lethality (13) . We found no interaction between α5β1-integrin and PA in the absence of divalent cation (Fig. S2) , strongly arguing that the interaction is mediated by the vWA/MIDAS domain of β1-integrin. The purified complex of β1-integrin with α4-integrin was not tested.
Functional Role of α-Integrin Components of β1-integrin Complexes in RAW264.7 Macrophage Sensitivity to LF-PA. The ability β1-integrin to bind to ligands depends on its prior interaction with a suitable α integrin partner (14) , which can be either α4 or α5 integrin-neither of which contain a vWA domain (14) . Monoclonal antibodies directed against specific epitopes in α integrins can prevent this interaction (15, 16) . We found that treatment of RAW264.7 macrophages with such anti-α4 (16) or anti-α5 (15) integrin antibodies increased survival of macrophages exposed to LF-PA (Fig. 3A) -providing further confirmation of the role of integrins in PA-dependent anthrax toxin lethality and establishing the role of αβ integrin complex formation in this process. Similarly, the purified α5β1-integrin complex also increased the ability of RAW264.7 macrophages to survive the lethality of LF-PA (Fig. 3B) suggesting that free αβ integrin complexes may be able to competitively inhibit the action of such complexes at the cell surface. Monoclonal antibodies that inhibit the formation of αβ complexes containing integrin αv (17) or β3 (19) had no detectable effect on the ability of these macrophages to survive exposure to LF-PA (Fig. 3A) , consistent with the absence of detectable β3 integrin on the surface of RAW264.7 macrophages (Fig. 2) (36, 37) and the absence of αv in integrin complexes containing β1. The anti-α5 integrin monoclonal antibody we used has a relatively low affinity for the ligand-binding site on its targeted integrin (http://www.biolegend.com) and showed a correspondingly small effect on anthrax toxicity. Control experiments indicated that none of the antibodies we tested detectably affected macrophage survival in the absence of the toxin (Fig. S3) Effects of CD44 and Hyaluronic Acid on LF-PA Lethality. The cell surface protein CD44 participates with OPN in the activation of integrins and increases their binding to ligands (30) (31) (32) . Fluo- rescence microscopy indicated that CD44 colocalizes with PA upon binding to the cell surface (Fig. S4) , as do integrins, but unlike integrins, CD44 was not detectably endocytosed along with PA. Additionally, as shown in Fig. 3A , a monoclonal antibody that blocks the interaction between CD44 and OPN (41) protected macrophages against late killing by LF-PA without affecting cell survival in the absence of the toxin (Fig. S3) . These results provide still further evidence to support the role of integrins in PA internalization and toxicity, and additionally argue that integrin activation is required for its PA-internalizing function.
The integrin-activating function of the CD44/OPN complex is antagonized by hyaluronic acid (HA), an anionic glycosaminoglycan (40) that interacts with CD44 and largely negates the integrin-activating effects of OPN and CD44. As we observed that integrin activation (40) is necessary for anthrax toxicity, we tested the effects of high molecular weight HA from human umbilical cord [estimated molecular weight of 3,420,000 Da (42)] on internalization of PA and on the lethality of the PA-LF complex. Addition of 100 μg/mL HA to cultures of RAW 264.7 macrophages reduced PA binding and PA entry into the cytoplasm by 50% to 70% as shown by fluorescence microscopy and Western blotting (Fig. 4 A-C) , and addition of HA also reduced β1-integrin-PA cytoplasmic colocalization during toxin internalization ( Fig. 4D and Fig. S5 )-consistent with the previously reported ability of HA to interfere with CD44-mediated integrin activation. However, addition of HA had no detectable effect on survival of macrophages treated with more than 50 ng/ mL LF (Fig. 4E) , suggesting that notwithstanding the modest decrease in binding and internalization of toxin resulting from antiintegrin measures, this toxin dose achieved sufficient internalization to achieve cell death. However, as was observed for antiintegrin antibodies, HA treatment at 100 μg/mL dramatically enhanced the ability of macrophages to survive exposure to toxin, increasing the IC 50 by 32-fold (from 0.12 ng/mL to 3.85 ng/mL) and higher concentrations of HA did not further affect LF-PA lethality (Fig. S6) . Low molecular weight HA degradation products have been reported to not bind to CD44 (43), and we found that HA products of Streptococcus pyogenes fermentation (900,000 Da, 132,000 Da, 16,100 Da, and 6,400 Da; R&D Systems), did not detectably change the LF-PA sensitivity of RAW264.7 cells.
Combined use of anti-β1-integrin monoclonal antibody with 100 μg/mL of HA did not result in any further reduction in cellular sensitivity to the toxin (Fig. 4E) , supporting the notion that these agents target the same pathway; similarly, the effects of HA and the knockdown of expression of ARAP3, which previously has been implicated in PA entry by an unknown mechanism (4), were nonadditive (Fig. 5A) . In contrast, however, siRNAinduced deficiency of LRP6, which complexes with CMG2 at the cell surface and colocalizes with that receptor, reduced macrophage sensitivity to LF-PA beyond what was observed at the Fig. 3 . Effect of antiintegrin inhibitory monoclonal antibodies on anthrax LF-PA-mediated lethality in RAW264.7 macrophages. (A) Effect of inhibition of antibody to integrin subunits α4, α5, αv, β1, and β3 or to the integrin-activating protein CD44. RAW264.7 cells were incubated for 24 h with 3 ng/mL PA and 500 ng/mL LF and in the presence of increasing amounts of purified monoclonal antibodies (0-10 μg/mL). (B) Soluble α5β1-integrin protein inhibits the LF-PA intoxication of RAW264.7 cells. RAW264.7 cells that express endogenous anthrax toxin receptors were incubated with 3 ng/mL PA and 500 ng/mL LF and in the presence of increasing amounts of purified α5β1-integrin protein (0-31.75 μg/mL) for 24 h. Integrin Effects on Early and Late LF-Mediated Killing of Macrophages. RAW264.7 macrophages have been reported to undergo LF-mediated killing by two distinct mechanisms: a rapid lytic death occurs in the presence of high LF concentrations, whereas a slow caspase-dependent apoptotic death is observed at low LF concentrations (44, 45) . A recent publication indicates that CMG2 is necessary for the lethality of high doses of anthrax toxin in mice and MEFs derived from them (13) . Using shRNA that reduced the steady-state level of CMG2 expression in RAW264.7 macrophages by 70%, we confirmed that CMG2 knockdown reduces the early death occurring after 4 h of exposure to more than 50 ng/mL LF (Fig. 5C) . However, the same knockdown of CMG2 did not affect late death, as assayed by survival after 24-h exposure to the same LF concentration (Fig. 5D) , implying that either the CMG2 expression remaining in these cells enabled entry of sufficient toxin to achieve late death, or alternatively, that late death can occur by a CMG2-independent mechanism. Only late death was observed in macrophages treated with a low concentration of LF (i.e., <1 ng/mL), as reported previously by Popov et al. (44) , and CMG2 deficiency had no detectable effect on this lethality (Fig. 5D) , arguing that late killing by low-dose toxin in macrophages is independent of CMG2. Interestingly, whereas the HA-mediated interference with integrin had no detectable effect on early macrophage death (Fig. 5C) , it further reduced the lethality to CMG2-deficent cells. The finding is consistent with our earlier evidence (Fig. 2 ) that antibody to integrin β1 reduces the ability of CMG2 to act as a PA receptor in RAW264.7 macrophages.
Discussion
The results reported here indicate a dual role for integrins in the entry of anthrax toxin into mouse macrophages. The ability of integrin complexes to respond to PA binding by conjointly entering the cytoplasm with PA, plus the finding that purified integrin α5β1 complexes can interact with purified PA with approximately the same affinity as TEM8 (10) , suggests that integrins can function as a PA receptor. Like both of the previously identified anthrax receptors, TEM8 and CMG2, β1-integrin includes a PA-binding vWA domain containing the MIDAS motif, which is absolutely conserved in cation-dependent ligand binding of integrins (14) . Structural analysis indicate that the vWA domains of CMG2 and integrin fold similarly (46) and PA-CMG2 complexes show mimicry of integrin-ligand interactions (12, 47) . However, the finding that integrin inactivation by antibodies or HA reduces the ability of concurrently present CMG2 to internalize PA and mediate lethality in RAW264.7 macrophages argues that integrins can also act as modulators of CMG2 receptor function.
Two distinct mechanism of killing of macrophages exposed to LF have been reported (28, 44) , and our investigations provide additional evidence of this. Macrophages treated with high doses of LF undergo rapid cell lysis and death (28, 44) , and-not surprisingly, given similar results obtained for mouse embryonic fibroblasts (13)-we show here that macrophage death occurring soon after exposure to the toxin is dependent on CMG2 function (Fig. 5C ). HA-mediated interference with integrin had no detectable effect on CMG2-dependent early macrophage death (Fig. 5C) . However, RAW264.7 macrophages defective in CMG2 expression nevertheless underwent eventual killing by toxin (Fig.  5D ), implying that a second mechanism exists for toxin entry in these cells. This mechanism, which necessarily cannot involve TEM8 [which is not present on the surface of macrophages (38, 39) ] was inhibited by HA (Fig. 5D) . Late apoptotic killing also occurs after exposure of macrophages to sublytic doses of LF (refs. 28, 44 and our data; Fig. 5D ), and such killing, although not affected by an shRNA-mediated decrease in CMG2 expression, was decreased by HA as well as by antibodies specific to β1-integrin and its α integrin partners. It is worth noting that integrins also mediate the lethality of the α toxin of Staphylococcus aureus (48, 49) , and that such killing by lytic or apoptotic mechanisms also appears to be concentration-dependent (50) .
The effects of maximal interference with integrin by HA are additive to those of knockdown of LRP6, a previously identified member of an anthrax toxin internalization complex (5, 9), whereas HA is nonadditive to knockdown of ARAP3, another modulator of PA entry (Fig. 5 A and B) . These findings suggest that ARAP3 and LRP6 affect different pathways of toxin internalization and that the ARAP3 pathway is at least partially congruent with the pathway of integrin-mediated internalization. During these experiments, we observed, surprisingly, that interference with different entry-modulating proteins has differential effects on the death of RAW264.7 macrophages induced by exposure to PA plus LF versus PA plus FP59, a hybrid toxin containing the PA binding site of LF plus a toxin domain derived from Pseudomonas aeruginosa exotoxin A.
The synergistic-rather than simply additive-effects of HA and shRNA directed against CMG2 on late death by sublytic LF concentrations suggest that integrin may enhance action of residual CMG2 remaining after shRNA knockdown, further supporting the notion that integrins can facilitate the receptor functions of CMG2. Similarly, TEM8 may also potentiate CMG2 knockout in addition to serving as a low-affinity receptor (13) . TEM8 has been reported to cooperate with integrin in regulating the VEGFR2 receptor (51) , and analogous cooperation between TEM8 and integrins may occur in regulation of CMG2-mediated toxin entry.
In animals, C57BL/6 mice containing null mutations in TEM8 and CMG2 survive toxin exposure (13) , suggesting that integrin function, which was not manipulated in the tested mice, was insufficient for LF lethality in the experimental system used. This may be attributable to the known differential expression of anthrax receptors among different host cells and tissues (2, 3, 10) , and potentially may result in part from a lack of relevant integrins on the surface of the yet-unidentified cells that mediate death of mice exposed to LF. Whereas CMG2 is necessary for normal killing of C57BL/6 mice, CMG2-null mutants were only partially protected from the effects of LF injections (13) , again suggesting the existence of an additional functional receptor, which was shown in these animals to be TEM8 (13) . However, the relevance of mouse models that use high-dose toxin injections or massive amounts of spores (13) to the natural process of anthrax infection can reasonably be questioned: rhesus monkey models that more closely resemble the conditions of human infection by B. anthracis have been observed to yield relatively low serum levels of toxin that are detected as a relatively late event (52, 53) .
Materials and Methods
Bioinformatics Analysis of Gene Expression. GABRIEL software (26) separated cancer cell lines (SK-MEL-5, SK-MEL28, M-14, MALME-3M, MDA-MB-435, MDA-N, SK-MEL-2, HL-60, MCF7, SW-620, EKVX, and A549) into two groups, LF-PA-sensitive and LF-PA-resistant, based on previous reports (9, (20) (21) (22) (23) (24) (25) . GABRIEL (27) was used for correlation of steady-state levels of expression with toxin lethality.
Chemicals and Reagents. PA and LF were purchased from List Biological Laboratories. The fluorescently labeled antibodies purchased from BioLegend were anti-CD44-APC, anti-β1-integrin-APC, anti-α4-integrin/Alexa Fluor 647, and anti-α5 integrin/Alexa Fluor 647. The preservative-free monoclonal antibodies purchased from BioLegend were anti-CD44 (IM7), anti-β1-integrin (HMβ1-1), anti-α4-integrin (R1-2), anti-α5 integrin (MFR5), anti-β3 integrin (HMβ3-1), and anti-αv integrin (RMV-7). High molecular weight HA from human umbilical cord was purchased from Sigma-Aldrich and HA from S. pyogenes of high, medium, low, and ultra-low molecular weight were purchased from R&D Systems.
Cell Culture. RAW264.7 mouse macrophage cells were maintained in DMEM (Invitrogen) supplemented with 10% FBS (HyClone) and 100 μg/mL penicillin and 100 μg/mL streptomycin. In this study we isolated single clones from a pool of ARAP3, LRP6 knockdown, and their respective WT RAW264.7 cell lines, which were described previously (4, 5) . For CMG2 knockdown experiment, lentiviral-based shRNAmir vector pGIPZ with sequence targeted for CMG2 was purchased from Open Biosystems. Viral infection of CMG2 shRNA was performed using lentiviral-based methods (4, 5) . Single RAW264.7 colonies were selected after puromycin treatment (4 μg/mL).
Toxin Treatment and Cell Viability Assays. Cells were treated with toxin for 4 or 24 h, and determination of cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed as described (4, 5) . Each data point shown in figures for MTT assays represents the average of results from four wells in each of at least three separate experiments. Cell viability is shown as the percentage of survivors obtained relative to treatment by PA alone (100%).
Antibody/Integrin Protection Assay. RAW264.7 cells (3 × 10 3 per well) were seeded in 96-well plates (100 μL/well) 24 h before the assay. The cells were then incubated at 37°C for 24 h with 3 ng/mL of PA, 500 ng/mL of LF, and serial dilutions of antibodies or purified α5β1-integrin (R&D Systems), followed by 24-h incubation in fresh, toxin-free media. The preservative-free monoclonal antibodies were suspended in the media at various concentrations. Toxin sensitivity was determined by MTT assay.
Immunofluorescence Microscopy. PA protein was labeled with Alexa Fluor 488 using the A10235 protein labeling kit (Molecular Probes). We determined by MTT assay that such labeling did not affect the ability of PA-LF to kill macrophages. For experiments determining the effects of β1 and β3 integrin inhibition or HA on toxin cell entry, cells were preincubated with 100 μg/mL HA or with 10 μg/mL of antimouse β1 or β3 integrin inhibitory monoclonal antibodies for 1 h in serum-free Iscove modified Dulbecco medium (IMDM; Invitrogen). Fresh serum-free IMDM media was added that contained 1 μg/mL PA/Alexa Fluor 488 alone or 1 μg/mL PA/Alexa Fluor 488 mixed with fresh 100 μg/mL HA or with 10 μg/mL of antimouse β1/β3 integrin inhibitory monoclonal antibodies. Cells were incubated for 60 min at 4°C for PA-binding analysis and for 20 min at 37°C for determination of PA internalization. For localization of integrins and CD44, cells were incubated with or without 1 μg/mL PA/Alexa Fluor 488, and with 0.5 μg/mL fluorescently labeled antibodies for 60 min at 4°C for PA-binding analysis and for 20 min at 37°C for PA-internalization analysis in serum-free IMDM media (Invitrogen). Cells were washed, fixed, and examined by using a fluorescence microscope (Leica).
Binding Kinetics. Experiments were performed using the Bio-Rad ProteOn XPR36 system. The extracellular portions of α5 and β1-integrins, devoid of their transmembrane and cytoplasmic domains, were cloned upstream of acidic and basic tails, and the heterodimer was expressed in and purified from CHO cell line by R&D Systems. The α5β1 heterodimer was functional based on its ability to bind fibronectin with K d of nanomolar range (R&D Systems). Protein concentration of α5β1-integrin was 0.2 μmol/L and the concentrations of PA ranged from 148 nmol/L to 12 μmol/L in PBS buffer with 1 mmol/L MnCl 2 . Equilibrium dissociation constants were calculated on the basis of the kinetic measurements of the association and dissociation rate constants according to the formula
Biochemical Assay of PA Binding and Internalization. Cells were grown to confluence and preincubated in serum-free IMDM media (Invitrogen) with 10 μg/mL of inhibitory monoclonal antibodies in β1 or β3 integrins or with 100 μg/mL of HA for 1 h before LF-PA exposure. Cells were exposed to 1 μg/mL of PA at 4°C for 1 h for binding assay or 100 ng/mL of PA at 37°C for 20 min for internalization assay in the presence or in the absence of HA or inhibitory antibody in serum-free IMDM media. Cells were then washed with cold PBS solution five times and lysed in RIPA buffer containing a protease inhibitor mixture (Roche). Western blot analysis was performed using rabbit polyclonal anti-PA antibody 7349.3 (kindly provided by G. Bokoch, Scripps Research Institute, La Jolla, CA) to detect monomeric PA, rabbit polyclonal anti-PA antibody (Abcam) to detect heptameric PA, or mouse antiactin monoclonal antibody (Sigma-Aldrich). Chemiluminescence of bands and their relative intensities were revealed using a VersaDoc 1000 instrument (Bio-Rad).
